Cyclacel Answers Celgene's Declaratory Judgment Complaint and Counterclaims for Infringement of Four Cyclacel Patents
June 18, 2010 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., June 18, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel Reports Interim Phase 2 Sapacitabine Data in Myelodysplastic Syndromes at 2010 ASCO Annual Meeting
June 07, 2010 15:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., June 7, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today interim response data from a Phase 2...
Cyclacel Pharmaceuticals to Report New Sapacitabine Phase 2 Interim Results in MDS at the American Society of Clinical Oncology Annual Meeting
May 21, 2010 08:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 21, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced that new interim data from an ongoing, multicenter, Phase 2 clinical...
Cyclacel Pharmaceuticals Reports Financial Results for First Quarter 2010
May 13, 2010 16:23 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 13, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel Pharmaceuticals to Restate 2009 Annual Financial Statements to Correct Net Loss per Share and Consolidated Statements of Cash Flows Disclosure and Filing Form 8-K for Non-Reliance on Previously Issued Financials Statements
May 13, 2010 16:01 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 13, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (the "Company"), a biopharmaceutical company developing oral therapies that target...
Cyclacel Pharmaceuticals to Announce Release of First Quarter 2010 Financial Results and Upcoming Corporate Events
May 07, 2010 16:01 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 7, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), announced upcoming corporate events.
Release of First Quarter 2010 Financial...
Cyclacel Receives Complaint Filed by Celgene Seeking to Avoid Certain Cyclacel Patents
April 30, 2010 16:30 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., April 30, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel's Innovative and Diverse Oncology Targeted Pipeline Highlighted in Six Presentations at AACR Annual Meeting
April 20, 2010 14:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., April 20, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel Pharmaceuticals Announces Multiple Abstracts Selected for Presentation at American Association for Cancer Research Annual Meeting
April 01, 2010 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., April 1, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) today announced that six abstracts highlighting translational and preclinical data...
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results
March 23, 2010 16:01 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., March 23, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today financial results for the fourth...